You must be a subscriber to see the full results of your search.
Please log in or subscribe below if you are not already a subscriber.
The Daily News subscribers get full access to more than
13
million names and addresses along with powerful search and download features.
Get the business leads you need with powerful searches of public records and notices.
Download listings into your spreadsheet or database.
Learn more about our services
| Search again
Editorial Results (free)
1.
FDA: New Suppliers to Ease 2 Cancer Drug Shortages -
Wednesday, February 22, 2012
TRENTON, N.J. (AP) – Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments.
2.
Ranbaxy Gets Final FDA OK for Generic Glaxo Drug -
Wednesday, August 12, 2009
NEW YORK (AP) - Generic drugmaker Ranbaxy Laboratories Ltd. said Tuesday its U.S. subsidiary received final U.S. Food and Drug Administration approval on two generic doses of the migraine drug Imitrex.
3.
Archived Article: Claritin P2 -
Monday, August 12, 2002
Claritin copycats might hit market soon Claritin copycats might hit market soon
A federal judge ruled patent claims on a derivative of allergy drug Claritin are invalid, a decision that could enable rival firms to sell copycat forms of Scher...
4.
Archived Article: Benchmark -
Thursday, October 18, 2001
Court ruling might Court ruling might
hurt consumer suits
A federal appellate court decision on a contested patent extension for Bristol-Myers Squibb Co.'s anti-anxiety drug BuSpar might aid the drug company's defense in upcoming lawsuits f...